Trial Profile
A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast (Daily Dosing and Intermittent, Episode-Driven Dosing) Compared With Placebo in the Treatment of Episodic Asthma in Children Aged 6 Months to 5 Years
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Asthma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms COMPLETED; IDEA
- Sponsors Merck & Co; Merck Sharp & Dohme; Organon
- 17 Jun 2019 This trial has been completed in France, according to European Clinical Trials Database.
- 04 Jul 2012 Company added in association field as reported by European Clinical Trials Database.
- 04 Jul 2012 Additional trial locations added as reported by European Clinical Trials Database.